Listening for Alzheimer's clues: machine learning analysis of multidomain speech features for cognitive impairment screening.

Saved in:
Bibliographic Details
Title: Listening for Alzheimer's clues: machine learning analysis of multidomain speech features for cognitive impairment screening.
Authors: Blazquez-Folch J; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Calm B; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Hinojosa-Calleja A; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., García-Gutiérrez F; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Alegret M; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Muñoz N; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Cano A; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Fernández MV; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Miguel A; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Solivar A; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., De Rojas I; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Valenzuela-Seba A; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., García-González P; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; PhD Program in Biotechnology, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain., Puerta R; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; PhD Program in Biotechnology, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain., Olivé C; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; PhD Program in Biotechnology, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain., Capdevila-Bayo M; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, University of Barcelona, Barcelona, Spain., Muñoz-Morales Á; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Bayón-Buján P; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Montrreal L; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Orellana A; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Ortega G; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Sanz-Cartagena P; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Rosende-Roca M; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Cantero-Fortiz Y; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Gurruchaga MJ; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain., Tarraga L; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Butler C; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Department of Brain Sciences, Imperial College London, London, United Kingdom.; The George Institute for Global Health, School of Public Health, Imperial College London, London, United Kingdom., Montalban X; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Department of Neurology and Multiple Sclerosis Center of Catalonia (Cemcat), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Boada M; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Ruiz A; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, United States.; Department of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, University of Texas Health Science Center, San Antonio, TX, United States., Marquié M; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Valero S; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Source: Frontiers in aging neuroscience [Front Aging Neurosci] 2026 May 04; Vol. 18, pp. 1816747. Date of Electronic Publication: 2026 May 04 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101525824 Publication Model: eCollection Cited Medium: Print ISSN: 1663-4365 (Print) Linking ISSN: 16634365 NLM ISO Abbreviation: Front Aging Neurosci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1663-4365
DOI:10.3389/fnagi.2026.1816747